Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
L.B. Foster | FSTR | Apr 17, 2024 | 24.79 | -0.28 |
L.S. Starrett | SCX | Apr 17, 2024 | 16.00 | -0.12 |
L3Harris Technologies | LHX | Apr 17, 2024 | 201.40 | +0.53 |
La Rosa Company | LRHC | Apr 17, 2024 | 1.60 | +8.47 |
La-Z-Boy | LZB | Apr 17, 2024 | 32.71 | -0.43 |
Labcorp | LH | Apr 17, 2024 | 199.97 | -0.97 |
Ladder Capital | LADR | Apr 17, 2024 | 10.25 | -0.10 |
Laird Superfood | LSF | Apr 17, 2024 | 2.28 | +2.70 |
Lake Shore Bancorp | LSBK | Apr 17, 2024 | 10.47 | -3.41 |
Lakeland Bancorp | LBAI | Apr 17, 2024 | 11.26 | -0.27 |
Lakeland Financial | LKFN | Apr 17, 2024 | 58.68 | -1.11 |
Lakeland Industries | LAKE | Apr 17, 2024 | 15.80 | -0.57 |
Lakeshore Acquisition II | LBBB | Apr 17, 2024 | 3.00 | 0.00 |
Lam Research | LRCX | Apr 17, 2024 | 912.26 | -5.29 |
Lamar Advertising A | LAMR | Apr 17, 2024 | 110.64 | -0.58 |
Lamb Weston | LW | Apr 17, 2024 | 80.36 | -2.07 |
LAMF Global Ventures I SPAC A | LGVC | Apr 17, 2024 | 6.88 | +1.33 |
Lancaster Colony | LANC | Apr 17, 2024 | 185.40 | -2.43 |
Landmark Bancorp | LARK | Apr 17, 2024 | 19.25 | -2.28 |
Landos Biopharma | LABP | Apr 17, 2024 | 21.67 | +0.70 |
Lands End | LE | Apr 17, 2024 | 12.84 | +1.30 |
Landsea Homes | LSEA | Apr 17, 2024 | 11.16 | -1.33 |
Landstar System | LSTR | Apr 17, 2024 | 168.03 | -3.50 |
Lantern Pharma | LTRN | Apr 17, 2024 | 5.99 | -0.17 |
Lantheus | LNTH | Apr 17, 2024 | 61.48 | -0.41 |
Lantronix | LTRX | Apr 17, 2024 | 3.11 | -3.72 |
Lanvin Group | LANV | Apr 17, 2024 | 1.50 | -6.83 |
Lanzatech Global | LNZA | Apr 17, 2024 | 3.06 | -1.29 |
Largecap Core Alphadex First Trust | FEX | Apr 17, 2024 | 93.80 | -0.26 |
Largecap Dividend Wisdomtree | DLN | Apr 17, 2024 | 68.68 | -0.12 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.